PDEX

MKT CAP:$166M

Pro-Dex, Inc.

Market Cap

$166M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$51.35+$13.63 (+36.15%)

Apr 22, 2026

Company Details

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers...

CEO

Richard Lee Van Kirk Jr.

IPO Date

Aug 7, 1986

Website

www.pro-dex.com

Key Metrics TTM

Revenue

$72M

+18.2% YoY

Net Income

$11M

EPS (Diluted)

$3.40

Free Cash Flow

$6M

Revenue / Share

$21.82

Gross Margin

28.3%

Operating Margin

15.7%

Net Margin

15.7%

FCF Margin

8.5%

P/S

2.3x

P/E

14.7x

Earnings Reports

Q3 2026

Apr 29, 2026

PENDING

Q2 2026

Jan 29, 2026

$19M+11.1%EPS $0.66

Q1 2026

Oct 30, 2025

$19M+24.4%EPS $1.40

FY 2025

Sep 4, 2025

$67M+23.7%EPS $2.67

Q4 2025

Sep 4, 2025

$17M+16.4%EPS $0.36

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$8M	$3M	$521.0K
Q4 21	$9M	$3M	$590.0K
Q1 22	$10M	$3M	$1M
Q2 22	$10M	$3M	$2M
Q3 22	$9M	$3M	$1M
Q4 22	$13M	$3M	$1M
Q2 23	$11M	$3M	$1M
Q2 24	$13M	$3M	$777.0K
Q3 24	$14M	$4M	$2M
Q4 24	$15M	$4M	$2M
Q1 25	$15M	$5M	$3M
Q2 25	$17M	$5M	$3M
Q3 25	$17M	$6M	$4M
Q4 25	$17M	$3M	$1M
Q1 26	$19M	$5M	$3M
Q2 26	$19M	$6M	$3M

Valuation

Quarter	P/S	P/E
Q2 21	3.4x	22.8x
Q4 21	2.9x	22.2x
Q1 22	2.5x	19.8x
Q2 22	2.3x	27.9x
Q3 22	1.7x	19.4x
Q4 22	1.3x	14.5x
Q2 23	1.4x	16.6x
Q2 24	1.5x	20.6x
Q3 24	1.2x	17.6x
Q4 24	1.2x	17.5x
Q1 25	1.8x	19.5x
Q2 25	2.5x	22.2x
Q3 25	2.5x	17.3x
Q4 25	2.1x	15.9x
Q1 26	1.6x	9.9x
Q2 26	1.8x	11.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	$2M	-$5M
Q4 21	$725.0K	-$198.0K
Q1 22	$3M	$2M
Q2 22	$2M	$1M
Q3 22	$213.0K	$7.0K
Q4 22	-$5M	-$6M
Q2 23	-$395.0K	-$904.0K
Q2 24	$710.0K	$77.0K
Q3 24	$4M	$4M
Q4 24	$1M	$913.0K
Q1 25	$2M	$1M
Q2 25	-$4M	-$5M
Q3 25	$754.0K	$574.0K
Q4 25	-$173.0K	-$266.0K
Q1 26	$2M	$2M
Q2 26	$4M	$4M

Capital Expenditures

Quarter	CapEx
Q2 21	$7M
Q4 21	$923.0K
Q1 22	$860.0K
Q2 22	$236.0K
Q3 22	$206.0K
Q4 22	$369.0K
Q2 23	$509.0K
Q2 24	$633.0K
Q3 24	$117.0K
Q4 24	$107.0K
Q1 25	$431.0K
Q2 25	$542.0K
Q3 25	$180.0K
Q4 25	$93.0K
Q1 26	$0
Q2 26	$70.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q2 21	+14.2%	+34.7%
Q4 21	+18.5%	+40.6%
Q1 22	+17.4%	+27.4%
Q2 22	-8.6%	-3.9%
Q3 22	+12.1%	+6.5%
Q4 22	+33.7%	+29.2%
Q2 23	+13.0%	+17.0%
Q2 24	+23.7%	+37.8%
Q3 24	+54.3%	+46.5%
Q4 24	+19.1%	+10.9%
Q1 25	+32.0%	+17.1%
Q2 25	+33.4%	+19.4%
Q3 25	+21.8%	+14.0%
Q4 25	+16.4%	+27.4%
Q1 26	+24.4%	+29.8%
Q2 26	+11.1%	+9.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$38.0K	0.5%
Q4 21	$393.0K	4.2%
Q1 22	$300.0K	3.0%
Q2 22	$275.0K	2.7%
Q3 22	$357.0K	3.9%
Q4 22	$343.0K	2.7%
Q2 23	$171.0K	1.5%
Q2 24	$197.0K	1.6%
Q3 24	$202.0K	1.4%
Q4 24	$17.0K	0.1%
Q1 25	$113.0K	0.8%
Q2 25	$130.0K	0.8%
Q3 25	$158.0K	0.9%
Q4 25	$154.0K	0.9%
Q1 26	$161.0K	0.9%
Q2 26	$164.0K	0.9%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q2 21	$989.0K	$936.0K	$150.0K
Q4 21	$1M	$1M	$175.0K
Q1 22	$980.0K	$1M	$37.0K
Q2 22	$615.0K	$1M	$22.0K
Q3 22	$658.0K	$1M	$20.0K
Q4 22	$726.0K	$2M	$12.0K
Q2 23	$467.0K	$951.0K	$68.0K
Q2 24	$788.0K	$1M	$37.0K
Q3 24	$760.0K	$1M	$17.0K
Q4 24	$836.0K	$864.0K	$38.0K
Q1 25	$843.0K	$1M	$48.0K
Q2 25	$942.0K	$1M	$49.0K
Q3 25	$947.0K	$1M	$113.0K
Q4 25	$905.0K	$1M	$133.0K
Q1 26	$768.0K	$1M	$73.0K
Q2 26	$734.0K	$2M	$39.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$5M	$1M	$6M
Q4 22	$849.0K	$755.0K	$2M
Q1 23	$3M	$813.0K	$4M
Q2 23	$382.0K	$1M	$2M
Q3 23	$2M	$1M	$3M
Q4 23	$3M	$4M	$7M
Q1 24	$2M	$1M	$3M
Q2 24	$1M	$6M	$7M
Q3 24	$3M	$5M	$8M
Q4 24	$3M	$4M	$7M
Q1 25	$3M	$5M	$8M
Q2 25	$66.0K	$5M	$5M
Q3 25	$4M	$5M	$10M
Q4 25	$419.0K	$7M	$7M
Q1 26	$514.0K	$10M	$11M
Q2 26	$8M	$864.0K	$9M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	4M	-2.1%	-2.4%
Q4 21	4M	-6.5%	-7.5%
Q1 22	4M	+0.7%	-5.5%
Q2 22	4M	-0.3%	-8.1%
Q3 22	4M	-0.5%	-6.6%
Q4 22	4M	-0.5%	-0.5%
Q2 23	4M	-2.1%	-3.3%
Q2 24	4M	-1.1%	-4.1%
Q3 24	4M	-2.4%	-6.0%
Q4 24	3M	-1.4%	-6.9%
Q1 25	3M	-5.2%	-9.9%
Q2 25	3M	+1.4%	-7.6%
Q3 25	3M	-0.0%	-5.3%
Q4 25	3M	+0.4%	-3.5%
Q1 26	3M	-0.3%	+1.4%
Q2 26	3M	-1.0%	-1.0%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	$70.6K	117
Q4 21	$80.0K	118
Q1 22	$84.6K	118
Q2 22	$86.2K	118
Q3 22	$78.5K	118
Q4 22	$93.4K	135
Q2 23	$83.6K	135
Q2 24	$86.2K	146
Q3 24	$97.9K	146
Q4 24	$101.5K	148
Q1 25	$100.6K	148
Q2 25	$113.5K	148
Q3 25	$117.7K	148
Q4 25	$96.7K	181
Q1 26	$102.4K	181
Q2 26	$103.1K	181

Revenue / Employee